GO
Loading...

Allergan Inc

More

  • Final Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Allergan fell$. 71 or. 4 percent, to $170.43. Boston Scientific Corp. rose$. 30 or 2.4 percent, to $12.85. Medtronic rose$. 30 or. 5 percent, to $62.71.

  • Early Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 11:16 AM ET

    Allergan rose $1.04 or. 6 percent, to $172.18. Baxter International Inc. rose$. 55 or. 7 percent, to $76.66. Boston Scientific Corp. rose$. 23 or 1.8 percent, to $12.78.

  • Ackman says Valeant-Allergan deal looks closer-CNBC Monday, 21 Jul 2014 | 1:11 PM ET

    July 21- Investor William Ackman, who owns nearly 10 percent of Botox maker Allergan Inc, said on Monday that the likelihood of Valeant Pharmaceuticals International Inc succeeding in its hostile takeover for Allergan increased on Monday.

  • Midday movers: Allergan, BB&T, McDonald's & More Monday, 21 Jul 2014 | 12:24 PM ET
    Trader on the floor of the New York Stock Exchange.

    Some of Monday's midday movers:

  • NEW YORK, July 21- U.S. stocks fell on Monday, following the sharpest moves in indexes in the past three months during the two previous sessions, as developments in Ukraine and Gaza continue to garner investor focus.

  • July 21- Allergan Inc, which is fighting off a hostile bid from Valeant Pharmaceuticals International Inc, said on Monday that it would cut 13 percent of its global workforce as part of a restructuring meant to boost profits over the next six years.

  • Faber Report: Allergan vs. Valeant     Monday, 21 Jul 2014 | 9:44 AM ET

    CNBC's David Faber reports Allergan is cutting 13 percent of its workforce and Valeant complains to the SEC and Canadian regulators about Allergan statements.

  • Elliott pushes to break up EMC     Monday, 21 Jul 2014 | 9:10 AM ET

    CNBC's David Faber reports activist investor Elliot Management reportedly has taken and more than $1 billion stake in EMC. And Allergan announces plans to cut 1,500 jobs as it continues fighting a takeover from Valeant.

  • July 21- Allergan Inc, which is fighting off a hostile bid from Valeant Pharmaceuticals International Inc, on Monday announced 1,500 jobs cuts as part of a $475 million restructuring meant to boost profits over the next six years.

  • Cramer's stocks to watch: AGN & VRX     Monday, 21 Jul 2014 | 8:53 AM ET

    CNBC's Jim Cramer shares his thoughts on the feud between Allergan and Valeant, and weighs in on how a slowdown in Europe would likely impact U.S. markets.

  • Allergan to cut 1,500 employees in restructuring Monday, 21 Jul 2014 | 8:44 AM ET

    Botox maker Allergan will cut about 13 percent of its workforce as part of a push to become more efficient while it fights a hostile takeover bid from Valeant Pharmaceuticals. Allergan Inc. has rejected several takeover attempts from Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman's Pershing Square Capital Management.

  • US futures lower on Ukraine, Middle East turmoil Monday, 21 Jul 2014 | 8:36 AM ET

    U.S. stock index futures pointed to a lower open on Monday, with investor sentiment subdued due to the ongoing turmoil in Gaza and Ukraine.

  • Allergan posts profit, plans to cut 13% of workforce Monday, 21 Jul 2014 | 8:25 AM ET
    A vial of Allergan’s Botox is arranged next to boxes for a photograph at a doctor's office in Manhattan Beach, Calif.

    Allergan on Monday said that its second-quarter profit and sales rose, and it announced $475 million in cost cuts.

  • July 21- Allergan Inc, which is fighting off a hostile bid from Valeant Pharmaceuticals International Inc, on Monday said that its second-quarter profit and sales rose, and it announced $475 million in cost cuts.

  • Early movers: GM, AGN, VRX, HAS, V, MA, IBM & more Monday, 21 Jul 2014 | 8:00 AM ET
    Traders work the floor of the New York Stock Exchange before the closing bell in New York.

    Some of the names on the move ahead of the open.

  • Valeant complains to regulators about Allergan Monday, 21 Jul 2014 | 7:07 AM ET
    Michael Pearson, CEO of Valeant Pharmaceuticals.

    Valeant has complained to regulators that claims made by Allergan to counter a hostile takeover are misleading, sources have told CNBC.

  • Valeant complains to SEC     Monday, 21 Jul 2014 | 7:05 AM ET

    Valeant contends Allergan claims are misleading and manipulative, reports CNBC's Andrew Ross Sorkin with the latest details on the feud between the two companies.

  • July 18- Valeant Pharmaceuticals Inc moved on Friday to blunt a key criticism by takeover target Allergan Inc of its Bausch+ Lomb business by releasing data showing strong sales growth.

  • Midday Glance: Medical Devices companies Friday, 18 Jul 2014 | 1:19 PM ET

    Allergan rose $1.25 or. 8 percent, to $167.07. Baxter International Inc. fell$. 25 or. 3 percent, to $76.00. Boston Scientific Corp. rose$. 18 or 1.4 percent, to $12.64.

  • July 18- Valeant Pharmaceuticals Inc moved on Friday to blunt a key criticism by takeover target Allergan Inc of its Bausch+ Lomb business by releasing data showing strong sales growth.